Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of May 13, 2025 • 7:01 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 04/27/2025 02:00 PM EDT | GlobeNewswire | Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager |
| 03/25/2025 04:30 PM EDT | GlobeNewswire | Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 |
| 03/10/2025 06:34 PM EDT | GlobeNewswire | Abpro Statement on the Departure of Former CEO Ian Chan |
| 12/12/2024 04:05 PM EST | GlobeNewswire | Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing |
| 01/22/2024 08:00 AM EST | GlobeNewswire | Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II |
| 03/03/2020 12:05 AM EST | GlobeNewswire | Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets |
Page
- 1
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.